| NCT Number | NCT06614686 |
| Lead Sponsor | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd |
| Conditions | Nasopharynx Cancer, Head and Neck Cancer |
| Enrollment | 20 participants |
| Start Date | 2024-09-20 |
| Primary Completion | 2026-10-31 (estimated) |
| Study Completion | 2027-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2024-09-26 |